journal article·2024-12Open access

One arrow two eagles: Multifunctional nano-system for macrophage reprogramming and osteoclastogenesis inhibition against inflammatory osteolysis

Tong Sha, Ze Wang, Jinwei Li, Yahong Wu, Jinbiao Qiang, Zhenming Yang, Yue Hu, Kaijuan Zheng, Shuyu Zhang, Haizhu Sun, Andrew K. Whittaker, Bai Yang, Hongchen Sun, Quan Lin, Ce Shi

Abstract

Inflammatory osteolysis poses a significant worldwide threat to public health. However, current monotherapies, which target either the prevention of the inflammatory response or the attenuation of osteoclast (OC) formation, have limited efficacy due to the complexity of the bone immune system being overlooked. Herein, by means of modifying salmon calcitonin (sCT), a multifunctional nano-system (AuNDs-sCT) was designed to synergistically inhibit OC differentiation and reverse the inflammatory microenvironment against inflammatory osteolysis. On the one hand, AuNDs-sCT effectively restrained OC differentiation by binding to the calcitonin receptors on the surface of OC precursors, resulting in the down-regulation of OC-specific genes and proteins. The targeted capacity of AuNDs-sCT provided a more durable and precise therapeutic effect. On the other hand, AuNDs-sCT exhibited antioxidant and anti-inflammatory effects, which regulated the polarization “switch” from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype in macrophages by the inhibition of NF-κB p65 phosphorylation, thereby effectively reversed the local inflammatory microenvironment. Additionally, AuNDs-sCT served as a promising fluorescent probe, enabling real-time visualization of the therapeutic process. This capability is expected to optimize drug administration and evaluate therapeutic effects. In summary, by inhibiting OC differentiation and reprogramming macrophages, AuNDs-sCT successfully realized drug repurposing and achieved the “one arrow two eagles” therapeutic strategy, which offers a synergistic and effective treatment option for the clinical management of inflammatory osteolysis. • “One arrow two eagles” therapeutic strategy is effective for inflammatory osteolysis. • The multifunctional nano-system (AuNDs-sCT) targeted osteoclasts and their precursors. • AuNDs-sCT reprogrammed macrophages and inhibited osteoclastogenesis simultaneously. • Promising fluorescent properties enabled the real-time visualization of therapeutic process.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone Metabolism and Diseases · Macrophage Migration Inhibitory Factor · Bone health and treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. Alpinetin ameliorates bone loss in LPS-induced inflammation osteolysis via ROS mediated P38/PI3K signaling pathway10.1016/j.phrs.2022.106400 ↗
2. Mechanism and prevention of titanium particle-induced inflammation and osteolysis10.3389/fimmu.2018.02963 ↗
3. Dendrobine attenuates osteoclast differentiation through modulating ROS/NFATc1/MMP9 pathway and prevents inflammatory bone destruction10.1016/j.phymed.2021.153838 ↗
4. Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial10.1002/art.23417 ↗
5. Inflammatory osteolysis: a conspiracy against bone10.1172/JCI93356 ↗
6. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems10.1038/nri2062 ↗
7. Inflammation-homing "living drug depot" for efficient arthritis treatment10.1016/j.actbio.2022.07.013 ↗
8. Opsonization inveigles macrophages engulfing carrier-free bilirubin/jph203 nanoparticles to suppress inflammation for osteoarthritis therapy10.1002/advs.202400713 ↗
9. Macrophages: development and tissue specialization10.1146/annurev-immunol-032414-112220 ↗
10. Macrophage polarization modulated by NF-κB in polylactide membranes-treated peritendinous adhesion10.1002/smll.202104112 ↗
11. Macrophage-biomimetic porous Se@SiO2 nanocomposites for dual modal immunotherapy against inflammatory osteolysis10.1186/s12951-021-01128-4 ↗
12. Molecular determinants for the polarization of macrophage and osteoclast10.1007/s00281-019-00754-3 ↗
13. Macrophage plasticity, polarization, and function in health and disease10.1002/jcp.26429 ↗
14. Hexapeptide-conjugated calcitonin for targeted therapy of osteoporosis10.1016/j.jconrel.2019.04.042 ↗
15. Calcitonin-induced change in serum calcium levels and its relationship to osteoclast morphology and number of calcitonin receptors10.1016/j.bone.2004.03.018 ↗
16. Supramolecular nanoparticles of calcitonin and dipeptide for long-term controlled release10.1016/j.jconrel.2017.04.014 ↗
17. Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis10.1080/17425255.2016.1175436 ↗
18. Drug repurposing: progress, challenges and recommendations10.1038/nrd.2018.168 ↗
19. Informatics on drug repurposing for breast cancer10.2147/DDDT.S417563 ↗
20. Novel strategies for tumor radiosensitization mediated by multifunctional gold-based nanomaterials10.1039/D2BM01496C ↗
21. Targeted chemo-photothermal treatments of rheumatoid arthritis using gold half-shell multifunctional nanoparticles10.1021/nn301215q ↗
22. Hybrid Au-star@Prussian blue for high-performance towards bimodal imaging and photothermal treatment10.1016/j.jcis.2022.12.043 ↗
23. A biomimetic nanoplatform with improved inflammatory targeting behavior for ROS scavenging-based treatment of ulcerative colitis
24. Au clusters treat rheumatoid arthritis with uniquely reversing cartilage/bone destruction10.1002/advs.201801671 ↗
25. Au nanocluster-modulated macrophage polarization and synoviocyte apoptosis for enhanced rheumatoid arthritis treatment10.1039/D2TB00869F ↗
26. Ligand engineering of gold nanoclusters for NIR-II imaging10.1021/acsanm.3c02888 ↗
27. Polycation-functionalized gold nanodots with tunable near-infrared fluorescence for simultaneous gene delivery and cell imaging10.1007/s12274-017-1860-4 ↗
28. Multifunctional nanoprobe for multi-mode imaging and diagnosis of metastatic prostate cancer10.1016/j.talanta.2023.124255 ↗
29. AuNCs-LHRHa nano-system for FL/CT dual-mode imaging and photothermal therapy of targeted prostate cancer10.1039/D2TB00531J ↗
30. Ultrasensitive detection of IgE levels based on magnetic nanocapturer linked immunosensor assay for early diagnosis of cancer10.1016/j.cclet.2021.08.117 ↗
31. The calcitonin receptor protects against bone loss and excessive inflammation in collagen antibody-induced arthritis10.1016/j.isci.2021.103689 ↗
32. Luteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades10.1002/jcp.26084 ↗
33. Scutellarein inhibits RANKL-induced osteoclast formation in vitro and prevents LPS-induced bone loss in vivo10.1002/jcp.27888 ↗
34. Astragalin mitigates inflammatory osteolysis by negatively modulating osteoclastogenesis via ROS and MAPK signaling pathway10.1016/j.intimp.2022.109278 ↗
35. A comparative evaluation of the immunotoxicity and immunomodulatory effects on macrophages exposed to aromatic trihalogenated DBPs10.1080/08923973.2019.1608444 ↗
36. 2-Phenylnaphthalene derivatives inhibit lipopolysaccharide-induced pro-inflammatory mediators by downregulating of MAPK/NF-κB pathways in RAW 264.7 macrophage cells10.1371/journal.pone.0168945 ↗
37. Sanguinarine inhibits osteoclast formation and bone resorption via suppressing RANKL-induced activation of NF-κB and ERK signaling pathways10.1016/j.bbrc.2012.12.051 ↗
38. One stone, three birds: multifunctional nanodots as "pilot light" for guiding surgery, enhanced radiotherapy, and brachytherapy of tumors10.1021/acscentsci.3c00994 ↗
39. Mechanisms of NF-κB p65 and strategies for therapeutic manipulation10.2147/JIR.S140188 ↗
40. The NF-kappaB family of transcription factors and its regulation10.1101/cshperspect.a000034 ↗
41. NF-κB pathways are involved in M1 polarization of RAW 264.7 macrophage by polyporus polysaccharide in the tumor microenvironment10.1371/journal.pone.0188317 ↗
42. Daphnetin attenuates LPS-induced osteolysis and RANKL mediated osteoclastogenesis through suppression of ERK and NFATc1 pathways10.1002/jcp.28408 ↗
43. Periplogenin attenuates LPS-mediated inflammatory osteolysis through the suppression of osteoclastogenesis via reducing the NF-κB and MAPK signaling pathways10.1038/s41420-024-01856-0 ↗